[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350122-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350122-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","viral-driven-oncogenesis-in-tnk-cell-lymphomas-parallels-and-divergences-between-htlv-1-and-ebv","Viral-driven oncogenesis in T/NK-cell lymphomas: parallels and divergences between HTLV-1 and EBV","","Viruses induce approximately 12% of human cancers, and T/NK cell neoplasms include adult T-cell leukemia-lymphoma (ATL) driven by HTLV-1 and extranodal NK/T-cell lymphoma (ENKTCL) or chronic active Epstein–Barr virus disease (CAEBV) associated with EBV. Proposed shared pathways involve viral genes—HTLV-1 tax and HBZ, and EBV LMP1 and miRNA-BART—that promote immune evasion and remodel host signaling to maintain infected-cell survival. Persistent infection enables somatic mutations and abnormal epigenetic changes, ultimately contributing to ATL, ENKTCL, and CAEBV-like lymphoma subsets, making disruption of these mechanisms a promising therapeutic direction for poor-prognosis viral lymphomas.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/viral-driven-oncogenesis-in-tnk-cell-lymphomas-parallels-and-divergences-between-htlv-1-and-ebv/350122/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/viral-driven-oncogenesis-in-tnk-cell-lymphomas-parallels-and-divergences-between-htlv-1-and-ebv/350122.png","ImageObject",300,407,{"name":42,"@type":43},"Aria Callaghan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do HTLV-1 and EBV drive oncogenesis in T/NK-cell lymphomas?","Question",{"text":63,"@type":64},"HTLV-1 and EBV contribute via viral strategies that enable persistence or latency, immune evasion, and modulation of host signaling pathways. Viral genes such as tax and HBZ for HTLV-1, and LMP1 and miRNA-BART for EBV, help infected cells survive and persist.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What downstream cellular events link long-term viral infection to lymphoma development?",{"text":68,"@type":64},"Long-term survival of infected cells leads to accumulation of somatic mutations and aberrant epigenetic alterations. These events ultimately contribute to ATL, ENKTCL, and lymphoma-like subsets of CAEBV.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is interrupting shared oncogenic mechanisms considered a promising therapy?",{"text":72,"@type":64},"The paper highlights that common viral-driven oncogenic mechanisms underpin lymphomas with poor prognoses. Targeting or interrupting these mechanisms could reduce persistence-driven progression and improve therapeutic outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350122,1790164374,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","International Journal of Hematology (2026) 123:476–486  \n[https://doi.org/10.1007/s12185-025-04156-0](https://doi.org/10.1007/s12185-025-04156-0)  \nPROGRESS IN HEMATOLOGY  \nRecent progress inT cell malignancies such as ATL  \nViral‑driven oncogenesis inT/NK‑cell lymphomas: parallelsand divergences between HTLV‑1 and EBV  \nTakafumi Shichijo1 · Jun‑ichirou Yasunaga1  \nReceived: 18 November 2025 / Revised: 19 December 2025 / Accepted: 25 December 2025 / Published online: 7 January 2026 © The Author(s) 2026  \nAbstract  \nViruses induce approximately 12% of human cancers, including lymphomas. In the case of T/NK cell neoplasms, human T-cell leukemia virus type I (HTLV-1) causes adult T-cell leukemia-lymphoma (ATL), and Epstein-Barr virus (EBV) is associated with extranodal NK/T-cell lymphoma (ENKTCL) and chronic active Epstein–Barr virus disease (CAEBV) . Common mechanisms for lymphoma development have been proposed. Viral genes, such as tax and HTLV-1 bZIP factor (HBZ) of HTLV-1, and latent membrane protein 1 (LMP1) and BamHI A rightward transcript microRNA (miRNA-BART) ofEBV, contribute to host immune evasion and modulation of host signaling pathways, resulting in the persistence of viral-infected cells. This viral strategy is closely associated with oncogenesis. Furthermore, the long-term survival of infected cells leads to the accumulation of somatic mutations and aberrant epigenetic alterations. These events eventually lead to ATL, ENKTCL, and the lymphoma-like subset of CAEBV. Interrupting these common oncogenic mechanisms is a promising therapeutic strategy for viral-driven lymphomas with poor prognoses.  \nKeywords Human T-cell leukemia virus type I · Adult T-cell leukemia-lymphoma · Epstein–Barr virus · Extranodal NK/Tcell lymphoma · Chronic active Epstein–Barr virus disease  \nIntroduction  \nInfections induce 15–20% of human cancers [1] . Almost all of these cancers are viral-driven (accounting for approximately 12% of all cancers), including hepatocellular carcinoma, gastric cancer, cervical cancer, nasopharyngeal carcinoma, Kaposi sarcoma, and lymphomas [2–4] . The oncogenic viruses responsible for these cancers include hepatitis B virus, human papillomavirus, Epstein-Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV)/ human herpes virus 8 (HHV-8), hepatitis C virus, human T-cell leukemia virus type I (HTLV-1), and human immunodeficiency virus [2–4] .  \n* Takafumi Shichijo[tshichijo@kumamoto-u.ac.jp](tshichijo@kumamoto-u.ac.jp)  \n* Jun-ichirou Yasunaga[jyasunag@kumamoto-u.ac.jp](jyasunag@kumamoto-u.ac.jp)  \n1 Department of Hematology, Rheumatology and Infectious Diseases, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto 860-8556, Japan  \nHTLV-1, EBV, and HHV-8 are well-known for inducing lymphomas and other lymphoproliferative diseases. HTLV-1 induces adult T-cell leukemia-lymphoma (ATL) [5], EBVis associated with Burkitt lymphoma, Hodgkin lymphoma (HL), post-transplant lymphoproliferative disorder, extranodal NK/T-cell lymphoma (ENKTCL), and chronic active Epstein–Barr virus disease (CAEBV) [6, 7], while HHV-8 causes Kaposi’s sarcoma, primary effusion lymphoma, multicentric Castleman’s disease, and HHV-8–positive diffuse large B-cell lymphoma (DLBCL) [7] .  \nMany viruses share common oncogenic mechanisms. Specifically, these mechanisms involve strategies for persistent or latent infection to evade host immunity and facilitate viral replication or the proliferation of infected cells [2] . Therefore, understanding the mechanisms underlying persistent viral infection can provide insight into potential therapeutic targets for virus-associated diseases.  \nIn this review, we summarize the recent findings on viraldriven oncogenesis in T/NK-cell lymphomas, focusing on HTLV-1 and EBV.  \nHuman T‑cell leukemia virus type I induces adult T‑cell leukemia‑lymphoma  \nHTLV-1 was the first retrovirus discovered in humans, and the first retrovirus proven to be oncogenic in humans (in 1980 and 1981, ","cbCaihXJ0CoDwQqg","https://ap.wps.com/l/cbCaihXJ0CoDwQqg","pdf",1920553,"English","# Abstract\n# Introduction\n# Human T-cell leukemia virus type I induces adult T-cell leukemia-lymphoma\n## HTLV-1 induces ATL\n## HTLV-1 proviral structure and oncogenesis","[{\"question\":\"How do HTLV-1 and EBV drive oncogenesis in T/NK-cell lymphomas?\",\"answer\":\"HTLV-1 and EBV contribute via viral strategies that enable persistence or latency, immune evasion, and modulation of host signaling pathways. Viral genes such as tax and HBZ for HTLV-1, and LMP1 and miRNA-BART for EBV, help infected cells survive and persist.\"},{\"question\":\"What downstream cellular events link long-term viral infection to lymphoma development?\",\"answer\":\"Long-term survival of infected cells leads to accumulation of somatic mutations and aberrant epigenetic alterations. These events ultimately contribute to ATL, ENKTCL, and lymphoma-like subsets of CAEBV.\"},{\"question\":\"Why is interrupting shared oncogenic mechanisms considered a promising therapy?\",\"answer\":\"The paper highlights that common viral-driven oncogenic mechanisms underpin lymphomas with poor prognoses. Targeting or interrupting these mechanisms could reduce persistence-driven progression and improve therapeutic outcomes.\"}]","Viral-driven oncogenesis in T/NK-cell lymphomas: parallels and divergences between HTLV-1 and EBV | PDF",1790087261,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8b7b01238cdcc39a3c2ec191981d78a.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41ca9b90242bcc4e24832f10cec075d6.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2446ee6c7382c2119b00726a61f82d1.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05f4a2c5c02048382c6c45815ae48b7a.webp",980,1301]